Tuesday 28th July 2015 |
Text too small? |
SeaDragon, which this month announced plans for a deeply discounted rights issue, expects annual sales to rise 60 percent in 2016, helping generate positive pretax earnings.
The Nelson based company forecasts revenue of $10.1 million in the year ending March 31, 2016, up from $6.3 million a year earlier, and expects earnings before interest, tax, depreciation, and amortisation of $144,000, compared to an Ebitda loss of $2.2 million in 2015, it said in a statement.
The forecast relies on SeaDragon completing its Omega-3 facility this calendar year, building a fractionation plant by July 2016 to make higher value products, the exchange rate remaining at about 70 US cents, gross margin staying largely unchanged and the company's ability to raise new funds, it said.
Earlier this month, SeaDragon announced plans to raise $5 million through a discounted rights issue and private placement to help fund the Nelson refinery, which has gone over budget and stretched the company's balance sheet. That was in addition to a $2.5 million convertible loan from cornerstone shareholder BioScience Managers.
The pick-up in sales is expected to generate positive operational cash flow in the 2016 financial year, with the capital injections and $3 million of additional bank funding covering the $7.5 million cost of building the factory.
SeaDragon shares were unchanged at 1.3 cents, and have slumped 41 percent this year. That compares to a 2.3 percent increase in the S&P/NZX All Index over the same period.
BusinessDesk.co.nz
No comments yet
PaySauce Quarterly Market Update - Dec 2024
CHI - FY24 Results Date and Audio Conference Details
AIA - December 2024 Monthly traffic update
January 15th Morning Report
PF - Details of Interim Results Webcast
Scott Secures NZ$18 million in Global Contracts for Protein
January 14th Morning Report
AFT - NEW YEAR LETTER TO INVESTORS
TruScreen Invited to Present WHO AI Collaboration Meeting
January 13th Morning Report